Publications by authors named "Robin Y Park"
Article Synopsis
- - The study explored the rate of sick notes (fit notes) issued for individuals recovering from COVID-19 in the years 2020, 2021, and 2022, highlighting the economic impact and health inequalities associated with long-term sickness absence.
- - Data was collected from the OpenSAFELY-TPP database, analyzing records from over 1.3 million people diagnosed with COVID-19 and comparing their sick note rates to a matched general population.
- - Results showed a decline in sick note rates over the years, with a peak in 2020 (4.88 per 100 person-months) and a decrease to 1.73 in 2022, suggesting that COVID-19's impact
Article Synopsis
- Obesity and rapid weight gain are linked to severe disease from COVID-19, with societal changes during the pandemic affecting health behaviors like nutrition and exercise, contributing to weight gain.
- A study analyzed healthcare records of over 17 million adults in England to assess weight gain before and during the pandemic, classifying individuals based on their rates of weight change and identifying those with significant increases.
- Using logistic regression, researchers examined various factors (age, sex, deprivation level, ethnicity) associated with rapid weight gain and the acceleration of weight gain during COVID-19.
Background: COVID-19 pandemic restrictions may have influenced behaviours related to weight.
Aim: To describe patterns of weight change among adults living in England with type 2 diabetes (T2D) and/or hypertension during the pandemic.
Design And Setting: An observational cohort study using the routinely collected health data of approximately 40% of adults living in England, accessed through the OpenSAFELY service inside TPP.
Article Synopsis
- The study aimed to determine patient eligibility and describe the coverage of antiviral drugs and neutralising monoclonal antibodies (nMAB) as treatments for COVID-19 in community settings in England.
- A retrospective analysis was conducted on data from 23.4 million people, focusing on outpatients with COVID-19 who were at high risk for severe outcomes between December 2021 and April 2022.
- Out of 93,870 high-risk patients identified, only 19,040 (20%) received treatment, with variations in treatment rates based on factors like age, ethnic background, risk group, and NHS region.
Article Synopsis
- The study aimed to determine how the effectiveness of COVID-19 vaccines wanes over a six-month period after the second dose, using data from primary care and hospital records.
- It included a large cohort of adults who had received either the BNT162b2 or ChAdOx1 vaccines and compared their health outcomes to unvaccinated individuals in various age and health vulnerability groups.
- Results showed that while vaccine effectiveness decreased over time, it remained significantly higher for vaccinated individuals, with more than 80% effectiveness for the BNT162b2 vaccine and 75% for ChAdOx1, even at six months post-vaccination.